Devices & Intervention · Note 06
Heart surgery outperforms TAVR in new 5-year study of young, low-risk patients
In a five-year study of younger, low-risk patients, surgical aortic valve replacement outperformed TAVR on key outcomes despite TAVR's slightly better in-hospital results.
Transcatheter aortic valve replacement changed aortic stenosis care by avoiding open surgery, and its use has expanded from older, high-risk patients toward younger and lower-risk groups. That expansion made a long-term comparison with surgery essential, because younger patients will live with the valve for decades.
In this five-year study of younger, low-risk patients, surgical aortic valve replacement was linked to key benefits even though TAVR had slightly better in-hospital outcomes. The result highlights the difference between procedural recovery and long-term durability: a less invasive procedure can be easier on the patient in the short term and still be the wrong trade if the valve fails sooner or requires reintervention.
The choice is not binary for every patient. Anatomy, frailty, concomitant coronary disease and patient preference all matter, and the trial population defines the boundary of the finding. The original report should be consulted for the specific endpoints and the rate of reintervention.
Keep in mind
- Surgery was linked to better five-year outcomes in younger low-risk patients.
- Long-term durability matters most in younger patients.
Source and reuse
This is an independent editorial summary written for Heartline. It is not a verbatim reproduction and does not reproduce paywalled text. Reporting, data and quotations belong to Cardiovascular Business. Read the original at the link provided.
Metadata basis: the publisher’s public RSS feed and the abstract it exposes. Where the full article could not be accessed, this note is explicitly metadata-based and limited to what the feed disclosed. It is not medical advice.
Read the original at Cardiovascular Business →